DULOXETINE AND QUINIDINE
Inhibitors of CYP2D6 are expected to increase duloxetine levels. This has been seen with fluoxetine and is predicted to occur with quinidine.
The manufacturer advises caution on concurrent use. Monitor for duloxetine adverse effects, which include nausea, dry mouth, and hot flushes.
(13)